PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, United Kingdom.\', \'Precision NanoSystems Inc, 655 West Kent Avenue North Unit 50, Vancouver, British Columbia V6P 6T7, Canada.\', \'Michael Smith Laboratories & School of Biomedical Engineering, University of British Columbia, 2185 East Mall, Vancouver, British Columbia V6T 1Z4, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1021/acs.molpharmaceut.2c00010
?:hasPublicationType
?:journal
  • Molecular pharmaceutics
is ?:pmid of
?:pmid
?:pmid
  • 35238565
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.572
?:rankingScore_hIndex
  • 102
is ?:relation_isRelatedTo_publication of
?:title
  • Current Status and Future Perspectives on MRNA Drug Manufacturing.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35238565>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35238565>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all